{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:41:02Z","timestamp":1777441262929,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,31]]},"DOI":"10.7759\/cureus.21786","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:01:37Z","timestamp":1643673697000},"source":"Crossref","is-referenced-by-count":3,"title":["Early Recognition and Successful Treatment of Anti-synthetase Syndrome"],"prefix":"10.7759","author":[{"given":"Arabi","family":"Rasendrakumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakanksha","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Bakhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CPM.0000000000000171","article-title":"The diagnosis and treatment of antisynthetase syndrome","volume":"23","author":"Witt LJ","year":"2016","unstructured":"Witt LJ, Curran JJ, Strek ME. The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med. 2016, 23:218-26. 10.1097\/CPM.0000000000000171","journal-title":"Clin Pulm Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2010.05.008","article-title":"Pulmonary manifestations of the idiopathic inflammatory myopathies","volume":"31","author":"Kalluri M","year":"2010","unstructured":"Kalluri M, Oddis CV. Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med. 2010, 31:501-12. 10.1016\/j.ccm.2010.05.008","journal-title":"Clin Chest Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051356","article-title":"Anti-aminoacyl transfer-RNA-synthetases (anti-tRNA) autoantibodies associated with interstitial lung disease: pulmonary disease progression has a persistent elevation of the Th17 cytokine profile","volume":"9","author":"Ramos-Martinez E","year":"2020","unstructured":"Ramos-Martinez E, Falf\u00e1n-Valencia R, P\u00e9rez-Rubio G, et al.. Anti-aminoacyl transfer-RNA-synthetases (anti-tRNA) autoantibodies associated with interstitial lung disease: pulmonary disease progression has a persistent elevation of the Th17 cytokine profile. J Clin Med. 2020, 9:1356. 10.3390\/jcm9051356","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2019.05.004","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"40","author":"Long K","year":"2019","unstructured":"Long K, Danoff SK. Interstitial lung disease in polymyositis and dermatomyositis. Clin Chest Med. 2019, 40:561-72. 10.1016\/j.ccm.2019.05.004","journal-title":"Clin Chest Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1590\/s1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon J","year":"2011","unstructured":"Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011, 37:100-9. 10.1590\/s1806-37132011000100015","journal-title":"J Bras Pneumol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/2049-6958-6-3-183","article-title":"Rituximab treatment in a case of antisynthetase syndrome with severe interstitial lung disease and acute respiratory failure","volume":"6","author":"Zappa MC","year":"2011","unstructured":"Zappa MC, Trequattrini T, Mattioli F, Rivitti R, Vigliarolo R, Marcoccia A, D'Arcangelo G. Rituximab treatment in a case of antisynthetase syndrome with severe interstitial lung disease and acute respiratory failure. Multidiscip Respir Med. 2011, 6:183-8. 10.1186\/2049-6958-6-3-183","journal-title":"Multidiscip Respir Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors GR","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?. Chest. 2010, 138:1464-74. 10.1378\/chest.10-0180","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2174\/157339710791330740","article-title":"Interstitial lung disease in idiopathic inflammatory myopathy","volume":"6","author":"Saketkoo LA","year":"2010","unstructured":"Saketkoo LA, Ascherman DP, Cottin V, Christopher-Stine L, Danoff SK, Oddis CV. Interstitial lung disease in idiopathic inflammatory myopathy. Curr Rheumatol Rev. 2010, 6:108-19. 10.2174\/157339710791330740","journal-title":"Curr Rheumatol Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000179949.65895.53","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"17","author":"Fathi M","year":"2005","unstructured":"Fathi M, Lundberg IE. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2005, 17:701-6. 10.1097\/01.bor.0000179949.65895.53","journal-title":"Curr Opin Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200011000-00005","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"12","author":"Hirakata M","year":"2000","unstructured":"Hirakata M, Nagai S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2000, 12:501-8. 10.1097\/00002281-200011000-00005","journal-title":"Curr Opin Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0176-8","article-title":"Antisynthetase syndrome","volume":"13","author":"Katzap E","year":"2011","unstructured":"Katzap E, Barilla-LaBarca ML, Marder G. Antisynthetase syndrome. Curr Rheumatol Rep. 2011, 13:175-81. 10.1007\/s11926-011-0176-8","journal-title":"Curr Rheumatol Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3023-x","article-title":"Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD)","volume":"34","author":"Rojas-Serrano J","year":"2015","unstructured":"Rojas-Serrano J, Herrera-Bringas D, Mej\u00eda M, Rivero H, Mateos-Toledo H, Figueroa JE. Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD). Clin Rheumatol. 2015, 34:1563-9. 10.1007\/s10067-015-3023-x","journal-title":"Clin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/81225-early-recognition-and-successful-treatment-of-anti-synthetase-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:12Z","timestamp":1707507432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/81225-early-recognition-and-successful-treatment-of-anti-synthetase-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.21786","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,31]]}}}